Amoena was the first company to introduce revolutionary breast form innovations for breast cancer survivors. Unlike others in the industry, Cornelius was never satisfied with the status quo of breast forms. He continued to research ways to further innovate product design and wearing comfort to create a form that felt more natural. In 1984, Amoena introduced a 2-layer breast form with a firm silicone “ring” on the rear side to stabilize the form in the bra and a new shape that mimicked the anatomy of a woman’s breast.

Amoena has registered over 25 patent families and has a history rich in growth, technological advancements and diversification. Here’s a glimpse at some of our most proud moments:

• 1984  Introduction of 2-layer breast forms
• 1988  Introduced patented Flowable Gel Back Layer breast forms
• 1989  Founded first Amoena subsidiaries in Europe
• 1992  First generation attachable breast forms after a patented manufacturing method
• 1992  Introduced a line of lingerie for breast cancer survivors post-surgery
• 1996  Launched pocketed swimwear
• 1996  Introduced lightweight silicone breast forms after a patented manufacturing method
• 1996  Introduced second generation attachable breast forms after a patented manufacturing method
• 2000  Introduced third generation attachable breast forms after a patented manufacturing method
• 2001  Patented Moldable Back Layer breast forms
• 2004  Introduced Tawny Lightweight breast forms
• 2005  Introduced patented Climate breast forms
• 2008  Patented Comfort+ Technology breast forms
• 2010  Introduced Amoena Energy breast forms with 3D pearl surface
• 2010  Launched Amoena's first bra product line designed for the general female consumer, Amoena Mia

Whereas Cornelius initially had little to no interest from our industry, Amoena’s position as industry leader and monumental growth eventually captured the attention of other companies. In 1994, Amoena Germany merged with the Breast Care Division of Coloplast A/S DK and eventually all Coloplast Breast Care subsidiaries became Amoena subsidiaries. Then, in 2007 Granville Baird Capital Partners invested in Amoena Group because of our position as the global market leader.

Amoena serves worldwide post-mastectomy markets including North, Central and South America; Europe, the Far East, Africa and the Pacific Rim. We market products through hospitals and clinics, and thousands of specialty boutiques and high-end retailers.

Cornelius Rechenberg had a vision and a steadfast determination to revolutionize the manufacturing process of breast forms. Although he passed away in 2000, his influence continues to guide our company’s mission and values. We remain committed to Cornelius’ vision and the women we proudly serve.